loadpatents
name:-0.062104225158691
name:-0.055593967437744
name:-0.010718107223511
Duan; Jingwu Patent Filings

Duan; Jingwu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Duan; Jingwu.The latest application filed is for "ror gamma modulators".

Company Profile
9.55.52
  • Duan; Jingwu - Yardley PA
  • - Yardley PA US
  • Duan; Jingwu - Newark DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
ROR .gamma. modulators
Grant 11,078,186 - Duan , et al. August 3, 2
2021-08-03
Heterocyclic compounds useful as modulators of TNF alpha
Grant 10,865,191 - Xiao , et al. December 15, 2
2020-12-15
Tricyclic sulfones as ROR.gamma. modulators
Grant 10,711,020 - Duan , et al.
2020-07-14
Ror Gamma Modulators
App 20200024257 - DUAN; Jingwu ;   et al.
2020-01-23
Tricyclic Sulfones As Ror Gamma Modulators
App 20190241588 - DUAN; Jingwu ;   et al.
2019-08-08
Cyclic compounds useful as modulators of TNF .alpha.
Grant 10,335,392 - Xiao , et al.
2019-07-02
Tricyclic heterocyclic compounds useful as inhibitors of TNF
Grant 10,308,652 - Wrobleski , et al.
2019-06-04
Tricyclic sulfones as ROR.gamma. modulators
Grant 10,273,259 - Duan , et al.
2019-04-30
Substituted tricyclic heterocyclic compounds
Grant 10,189,840 - Xiao , et al. Ja
2019-01-29
Heterocyclic Compounds Useful As Modulators Of Tnf Alpha
App 20180222883 - XIAO; Hai-Yun ;   et al.
2018-08-09
Cyclic Compounds Useful As Modulators Of Tnf Alpha
App 20180221344 - Xiao; Hai-Yun ;   et al.
2018-08-09
Substituted Tricyclic Heterocyclic Compounds
App 20180111936 - XIAO; Hai-Yun ;   et al.
2018-04-26
Tricyclic Heterocyclic Compounds Useful As Inhibitors Of Tnf
App 20180111937 - WROBLESKI; Stephen T. ;   et al.
2018-04-26
Tricyclic Sulfones As Ror Gamma Modulators
App 20180002358 - Duan; Jingwu ;   et al.
2018-01-04
Tricyclic sulfones as ROR.gamma. modulators
Grant 9,815,859 - Duan , et al. November 14, 2
2017-11-14
Carbocyclic sulfone ROR.gamma. modulators
Grant 9,771,320 - Duan , et al. September 26, 2
2017-09-26
ROR.gamma. modulators
Grant 9,725,443 - Dhar , et al. August 8, 2
2017-08-08
Cyclohexyl sulfone ROR.gamma. modulators
Grant 9,708,253 - Duan , et al. July 18, 2
2017-07-18
ROR.gamma. modulators
Grant 9,663,469 - Dhar , et al. May 30, 2
2017-05-30
Heterocyclic sulfone ROR.gamma. modulators
Grant 9,637,455 - Duan , et al. May 2, 2
2017-05-02
TRICYCLIC SULFONES AS RORy MODULATORS
App 20160326195 - Duan; Jingwu ;   et al.
2016-11-10
Pyrrolidinyl Sulfone Derivatives And Their Use As Ror Gamma Modulators
App 20160326108 - DUAN; Jingwu ;   et al.
2016-11-10
Heterocyclic Sulfone Ror Gamma Modulators
App 20160326115 - Duan; Jingwu ;   et al.
2016-11-10
Cyclohexyl Sulfone Ror Gamma Modulators
App 20160326104 - DUAN; Jingwu ;   et al.
2016-11-10
Carbocyclic Sulfone Ror Gamma Modulators
App 20160326103 - Duan; Jingwu ;   et al.
2016-11-10
RORy MODULATORS
App 20160318870 - Dhar; T.G Murali ;   et al.
2016-11-03
Pyrrolidinyl sulfone ROR.gamma. modulators
Grant 9,458,171 - Duan , et al. October 4, 2
2016-10-04
RORgamma MODULATORS
App 20160229844 - Dhar; T. G. Murali ;   et al.
2016-08-11
Pyrrolidinyl Sulfone Rorgamma Modulators
App 20150191483 - Duan; Jingwu ;   et al.
2015-07-09
Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity
Grant 9,040,526 - Mangion , et al. May 26, 2
2015-05-26
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
Grant 8,987,268 - Wrobleski , et al. March 24, 2
2015-03-24
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
Grant 08921368 -
2014-12-30
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseases
Grant 8,921,368 - Wrobleski , et al. December 30, 2
2014-12-30
Azaindazoles as kinase inhibitors and use thereof
Grant 8,846,673 - Duan , et al. September 30, 2
2014-09-30
Pyrrolopyridazine Jak3 Inhibitors And Their Use For The Treatment Of Inflammatory And Autoimmune Diseases
App 20140011795 - Wrobleski; Stephen T. ;   et al.
2014-01-09
Pyrrolopyridazine Jak3 Inhibitors And Their Use For The Treatment Of Inflammatory And Autoimmune Diseases
App 20140011800 - Wrobleski; Stephen T. ;   et al.
2014-01-09
Nicotinamide compounds useful as kinase modulators
Grant 8,586,751 - De Lucca , et al. November 19, 2
2013-11-19
Indane modulators of glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity and use thereof
Grant 8,324,401 - Duan , et al. December 4, 2
2012-12-04
Benzylpyrrolidinone Derivatives As Modulators Of Chemokine Receptor Activity
App 20120295899 - Mangion; Ian K. ;   et al.
2012-11-22
Fused heteroaryl modulators of glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity and use thereof
Grant 8,304,539 - Duan , et al. November 6, 2
2012-11-06
Azaindazoles As Kinase Inhibitors And Use Thereof
App 20120129852 - Duan; Jingwu ;   et al.
2012-05-24
Nicotinamide Compounds Useful As Kinase Modulators
App 20120082702 - DeLucca; George V. ;   et al.
2012-04-05
Modulators of glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity and use thereof
Grant 8,034,940 - Weinstein , et al. October 11, 2
2011-10-11
Modulators of glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity, and use thereof
Grant 7,888,381 - Duan , et al. February 15, 2
2011-02-15
FUSED HETEROARYL MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kappaB ACTIVITY AND USE THEREOF
App 20110002952 - Duan; Jingwu ;   et al.
2011-01-06
INDANE MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
App 20090325961 - Duan; Jingwu ;   et al.
2009-12-31
Modulators of the glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity and use thereof
Grant 7,625,921 - Duan , et al. December 1, 2
2009-12-01
Barbituric acid derivatives as inhibitors of TNF-.alpha. converting enzyme (TACE) and/or matrix metalloproteinases
Grant 7,595,317 - Duan , et al. September 29, 2
2009-09-29
Indane modulators of glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity and use thereof
Grant 7,592,461 - Duan , et al. September 22, 2
2009-09-22
Modulators of the glucocorticoid receptor, AP-1, and/or NF-.kappa.B activity and use thereof
Grant 7,569,689 - Duan , et al. August 4, 2
2009-08-04
MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF
App 20090075995 - Weinstein; David S. ;   et al.
2009-03-19
Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-.alpha. converting enzyme (TACE)
Grant 7,482,372 - Sheppeck , et al. January 27, 2
2009-01-27
Barbituric acid derivatives as inhibitors of TNF-.alpha. converting enzyme (TACE) and/or matrix metalloproteinases
Grant 7,294,624 - Duan , et al. November 13, 2
2007-11-13
Indane modulators of glucocorticoid receptor, AP-1, and/or NF/kB activity and use thereof
App 20070185056 - Duan; Jingwu ;   et al.
2007-08-09
BARBITURIC ACID DERIVATIVES AS INHIBITORS OF TNF-alpha CONVERTING ENZYME (TACE) AND/OR MATRIX METALLOPROTEINASES
App 20070167451 - Duan; Jingwu ;   et al.
2007-07-19
Modulators of glucocorticoid receptor, AP-1, and/or NF-kB activity, and use thereof
App 20070129400 - Duan; Jingwu ;   et al.
2007-06-07
Hydantoin derivatives as inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)
Grant 7,132,432 - Duan , et al. November 7, 2
2006-11-07
Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or TNF-.alpha. converting enzyme (TACE)
Grant 7,015,217 - Duan , et al. March 21, 2
2006-03-21
Matrix metalloproteinase inhibitors
Grant 6,989,139 - Decicco , et al. January 24, 2
2006-01-24
Cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha.
Grant 6,984,648 - Lu , et al. January 10, 2
2006-01-10
Spiro-cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha. converting enzyme (TACE)
Grant 6,962,938 - Ott , et al. November 8, 2
2005-11-08
Barbituric acid derivatives as inhibitors of TNF-.alpha. converting enzyme (TACE) and/or matrix metalloproteinases
Grant 6,936,620 - Duan , et al. August 30, 2
2005-08-30
Modulators of the glucocorticoid receptor, AP-1, and/or NF-kB activity and use thereof
App 20050182082 - Duan, Jingwu ;   et al.
2005-08-18
Modulators of the glucocorticoid receptor, AP-1, and/or NF-kappaB activity and use thereof
App 20050176716 - Duan, Jingwu ;   et al.
2005-08-11
Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
App 20050171096 - Sheppeck, James E. ;   et al.
2005-08-04
Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-.alpha. converting enzyme (TACE)
Grant 6,906,053 - Sheppeck , et al. June 14, 2
2005-06-14
Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-.alpha. converting enzyme (TACE)
Grant 6,890,915 - Sheppeck , et al. May 10, 2
2005-05-10
Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-.alpha. converting enzyme (TACE)
Grant 6,884,806 - Decicco , et al. April 26, 2
2005-04-26
Matrix Metalloproteinase Inhibitors
App 20050025702 - Decicco, Carl P. ;   et al.
2005-02-03
Hydantoin derivatives as inhibitors of tumor necrosis factor-alpha converting enzyme (TACE)
App 20040254231 - Duan, Jingwu ;   et al.
2004-12-16
Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
App 20040209874 - Sheppeck, James E. ;   et al.
2004-10-21
Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha
App 20040162426 - Lu, Zhonghui ;   et al.
2004-08-19
Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-.alpha. converting enzyme (TACE)
Grant 6,770,647 - Sheppeck , et al. August 3, 2
2004-08-03
Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha converting enzyme (TACE)
App 20040132693 - Ott, Gregory R. ;   et al.
2004-07-08
Cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha.
Grant 6,743,807 - Duan , et al. June 1, 2
2004-06-01
Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF- .alpha. converting enzyme (TACE)
Grant 6,740,649 - Ott , et al. May 25, 2
2004-05-25
Beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha
App 20040072802 - Duan, Jingwu ;   et al.
2004-04-15
Spiro-cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha. converting enzyme (TACE)
Grant 6,720,329 - Ott , et al. April 13, 2
2004-04-13
Amide derivatives as inhibitors of matrix metalloproteinases, TNF-.alpha., and aggrecanase
Grant 6,689,771 - Duan , et al. February 10, 2
2004-02-10
Barbituric acid derivatives as inhibitors of TNF-alpha converting enzyme (TACE) and/or matrix metalloproteinases
App 20030229084 - Duan, Jingwu ;   et al.
2003-12-11
Combined use of tace inhibitors and COX2 inhibitors as anti-inflammatory agents
App 20030225054 - Duan, Jingwu
2003-12-04
Beta-sulfone derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
App 20030212056 - Duan, Jingwu ;   et al.
2003-11-13
Bicyclic lactam derivatives as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
App 20030181438 - Decicco, Carl P. ;   et al.
2003-09-25
Lactam metalloprotease inhibitors
Grant 6,620,823 - Maduskuie , et al. September 16, 2
2003-09-16
Barbituric acid derivatives as inhibitors of TNF-alpha converting enzyme (TACE) and/or matrix metalloproteinases
App 20030166647 - Duan, Jingwu ;   et al.
2003-09-04
Lactam metalloprotease inhibitors
Grant 6,610,731 - Duan , et al. August 26, 2
2003-08-26
Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or TNF-Alpha converting enzyme (TACE)
App 20030149031 - Duan, Jingwu ;   et al.
2003-08-07
Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
App 20030139388 - Ott, Gregory R. ;   et al.
2003-07-24
Novel lactam metalloprotease inhibitors
App 20030134827 - Duan, Jingwu ;   et al.
2003-07-17
Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
App 20030130273 - Sheppeck, James E. ;   et al.
2003-07-10
Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
App 20030130257 - Sheppeck, James E. ;   et al.
2003-07-10
Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha converting enzyme (TACE)
App 20030087882 - Ott, Gregory R. ;   et al.
2003-05-08
Novel amide derivatives as inhibitors of matrix metalloproteinases, TNF-alpha, and aggrecanase
App 20030032803 - Duan, Jingwu ;   et al.
2003-02-13
Lactam inhibitors of matrix metalloproteinases, TNF-.alpha. and aggrecanase
Grant 6,495,548 - Duan December 17, 2
2002-12-17
.beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha.
Grant 6,495,565 - Duan , et al. December 17, 2
2002-12-17
Lactam metalloprotease inhibitors
Grant 6,403,632 - Duan , et al. June 11, 2
2002-06-11
Amide derivatives as inhibitors of matrix metalloproteinases, TNF-.alpha., and aggrecanase
Grant 6,376,665 - Duan , et al. April 23, 2
2002-04-23
Novel lactam metalloprotease inhibitors
App 20020042398 - Maduskuie, Thomas P. ;   et al.
2002-04-11
Cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-alpha
App 20020016336 - Duan, Jingwu ;   et al.
2002-02-07
Beta-Amino-Acid derivatives as inhibitors of matrix metalloproteases and TNF-Alpha
App 20020013341 - Duan, Jingwu ;   et al.
2002-01-31
Lactam metalloprotease inhibitors
Grant 6,057,336 - Duan , et al. May 2, 2
2000-05-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed